Hemostemix Inc (HEM) — Cash Flow-to-Debt Ratio
Hemostemix Inc (HEM) has a Cash Flow-to-Debt Ratio of -0.61x as of September 2025, meaning its operating cash flow of CA$-2.91 Million could theoretically repay -1% of its total liabilities (CA$4.80 Million) in one year. See Hemostemix Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hemostemix Inc Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Hemostemix Inc across 12 annual periods. Also explore HEM year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Hemostemix Inc (2013–2024)
Year-by-year debt coverage analysis for Hemostemix Inc. For market capitalisation and broader financial context, see Hemostemix Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.23x | CA$-1.90 Million | CA$8.20 Million | ▼ -19.1% |
| 2023 | -0.19x | CA$-1.50 Million | CA$7.68 Million | ▲ +76.9% |
| 2022 | -0.84x | CA$-6.10 Million | CA$7.23 Million | ▼ -41.8% |
| 2021 | -0.59x | CA$-3.48 Million | CA$5.85 Million | ▲ +65.9% |
| 2020 | -1.75x | CA$-5.98 Million | CA$3.42 Million | ▼ -112.9% |
| 2019 | -0.82x | CA$-3.40 Million | CA$4.15 Million | ▲ +64.2% |
| 2018 | -2.29x | CA$-2.69 Million | CA$1.17 Million | ▲ +66.9% |
| 2017 | -6.91x | CA$-3.21 Million | CA$464.79K | ▼ -848.1% |
| 2016 | -0.73x | CA$-2.69 Million | CA$3.69 Million | ▲ +87.2% |
| 2015 | -5.69x | CA$-3.55 Million | CA$622.73K | ▼ -0.2% |
| 2014 | -5.68x | CA$-3.13 Million | CA$551.70K | ▼ -24.7% |
| 2013 | -4.56x | CA$-1.11 Million | CA$242.98K | — |